The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor

Nature Medicine

Volumn 4, Issue 1, 1998, Pages 92-96

  Calleja, C ^a   Pascussi, J M ^a   Mani, J C ^b   Maurel, P ^a   Vllarem, M J ^a  

^a NSERM Unité 128   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; RIFAMPICIN;

AIDS RELATED COMPLEX; ARTICLE; CELL STRAIN HEPG2; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RECEPTOR BINDING; EPIDEMIC; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOREGULATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; CHO CELLS; COS CELLS; CRICETINAE; DEXAMETHASONE; HUMANS; KINETICS; LIGANDS; LUCIFERASES; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; RIFAMPIN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031914323     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0198-092     Document Type: Article

References (43)

1. Yamamoto, K.R. Steroid receptor regulated transcription of specific gene and gene networks. Annu. Rev. Genet. 19, 209-211 (1985).
2. Green, S. & Chambon, P., Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4, 309-314 (1988).
3. Beato, M. Gene regulation by steroid hormones. Cell 56, 335-339 (1989).
4. Ringold, G.M. Steroid-hormone regulation of gene expression. Annu. Rev. Pharmacol. Toxicol. 25, 529-566 (1985).
5. Mitchison, D.A. Understanding the chemotherapy of tuberculosis-current problems [The Garrod lecture]. J. Antimicrob. Chemother. 29 (5), 477-493 (1992).
6. Mitchell, L., Wendon, J., Fitt, S. & Williams, R. Anti-tuberculous therapy and acute liver failure. Lancet 4, 555-556 (1995).
7. Corcos, L. Phenobarbital and dexamethasone induce expression of cytochrome P450 genes from subfamilies IIB, IIC, and IIIA in mouse liver. Drug. Metab. Dispos. 20, 797-801 (1992
8. Cresteil, T., et al. Induction of drug-metabolizing enzymes by tricyclic antide- pressants in human liver: Characterization and partial resolution of cytochromes P450. Br. I. Clin. Pharmacol. 16, 651-657 (1983).
9. Pichard, L., et al. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol. Pharmacol. 41, 1047-1055 (1992).
10. O'Malley, B.W. & Tsai, M.J. Molecular pathways of steroid receptor action. Biol. Reprod. 46 (2), 163-167 (1992).
11. Ibrahim, M.S., Maged, Z.A., Haron, A., Khalil, R.Y. & Attllah, A.M. Antibiotics and immunity: Effect of antibiotics on natural killer, antibody dependent cellmediated cytotoxicity and antibody production. Chemioterapia 6, 426-430 (1987).
12. Nessi, R., Pallanza, R. & Fowst, G. Rifampicin and Immunosuppression. Arzneim.-Forsch. 24 (5), 832-836 (1974).
13. Baumann, H., Jahreis, G.P. & Morella, K.K. Interaction of cytokine - and glucocorticoid-response elements of acute-phase plasma protein genes: Importance of glucocorticoid beta-fibrinogen genes, J. Biol. Chem. 265, 22275-22281 (1990).
14. Gradin, K., Whitelaw, M.L., Toftgard, R., Poellinger, L. & Berghard, A.J. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269, 23800-23807 (1994).
15. Ning, Y.-M. & Sánchez, E.R. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J. Biol. Chem. 268, 6073-6076 (1993).
16. Green, S. & Chambon, P. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 325, 7578 (1987).
17. Kumar, V., et al. Functional domains of the human estrogen receptor. Cell 51, 941-951 (1987).
18. McGregor, D.B., Edwards, I., Wolf, C.R., Forrester, L.M. & Caspary, W.J. Endogenous xenobiotic enzyme levels in mammalian cells. Mutat. Res. 261, 29-39 (1991).
19. Moguilewsky, M. & Philibert, D. RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J. Steroid. Biochem. 20, 271-276 (1984).
20. Lanford, R.E., Carey, K.D., Estlack, L.E., Smith, G.C. & Hay, R.V., Analysis of plasma protein synthesis in long-term primary cultures of baboon hepatocytes maintained in a serum-free medium. In Vitro Cell. Dev. Biol. 25, 174-182 (1989).
21. Ourlin, J.C., Vilarem, M.J., Daujat, M., Harricanne, M.C. & Maurel, P. Lipid-mediated transfection of normal adult human hepatocytes in primary culture. Anal. Biochem. 247, 34-44 (1997).
22. Benhamou, B., et al. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 256, 206-209 (1992).
23. Wutz, J.M, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3, 87-94 (1996).
24. Denis, M., Poellinger, L, Wikstöm A.C. & Gustafsson, J. Requirement of hormone for thermal conversion of the glucocorticoid receptor to a DNA-binding state. Nature 333, 686-688 (1988).
25. Bhakoo, H.S., Paolini, N.S., Milholland, R.J., Lopez, R.E. & Rosen, F. Glucocorticoid receptors and the effect of glucocorticoids on the growth of B16 melanoma. Cancer Res. 41, 1695-1701 (1981).
26. Fägerstam, L.G. & Karlsson, R. Biosensor techniques, in Immunochemistry (eds. Van Oss, C.J., & Van Regenmorte, M.) 949-970 (Marcel Dekker, New York, 1993).
27. Fagerstam, L.G. & O'Shannessy, D.J., Surface plasmon resonance detection in affinity technologies. Handb. Affinity Chromatogr. 63, 229-252 (1993).
28. Malmqvist, M, Biospecific interaction analysts using biosensor technology. Nature 361, 186-187 (1993).
29. Yu, C., Warriar, N. & Govindan, M. V. Cysteines 638 and 665 in the hormone binding domain of human glucocorticoid receptor define the specificity to glucocorticoid receptor. Biochemistry 34, 14163-14173 (1995).
30. Xu, M., Chakraborti, P. K., Garabedian, M.J., Yamamoto, K.R, & Simons, S.S. Molecular structure of glucocorticoid receptor domains is not equivalent to functional independence. J. Biol. Chem. 271, 21430-21438 (1996).
31. Simons, S.S., Sistare, F.D. & Chakraborti, P.K. Steroid binding activity is retained in a 16-kDa fragment of the steroid binding domain of rat glucocorticoid receptors. J. Biol. Chem. 254, 14493-14497 (1989).
32. Kraus, W.L., Mclnerney, E.M. & Katzenellenbogen, B.S. Ligand-dependent transcriptionally productive association of the amino and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA 92, 12314-12318 (1995).
33. Langley, E., Zhou, Z. & Vilson, E.M., Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270, 29983-29990 (1995).
34. Vacca, A., et al. Glucocorticoid receptor-mediated suppression of the Interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements, J. Exp. Med. 175, 637-646 (1992).
35. Jonat, C., et al. Antitumor promotion and anti-inflammation down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204 (1990).
36. Watkins, P.B., Role of cytochrome P450 in drug metabolism and hepatotoxidty. Semin. Liver. Dis. 10, 235-250 (1990).
37. Gao, X. & Huang, L. A novel cationic liposome, reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Comm. 179, 280-285 (1991).
38. Pichard, L., et al. Cyclosporin A drug interaction: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and liver microsomes. Drug. Metab. Dispos. 18, 595-606 (1990).
39. Durand, D.B., et al. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8, 1715-1724 (1988).
40. Angel, P., et al, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739 (1990).
41. Neuman, J.R., Morency, C.A. & Russian, K.O., A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5, 444 (1987).
42. O'Shanessy, D.J., Brigham-Burke, M, Sonseson, K.K., Hensley, P. & Brooks, I. Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. Methods Enzymol. 249, 323-349 (1994).
43. Karlsson, R., Ross, H., Fägerstam, L. & Persson, B. Kinetic and concentration analysis using BIA technology. Methods 6, 99-110 (1994).